首页 | 本学科首页   官方微博 | 高级检索  
     


Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine
Authors:Geetanjali B. Tomar  Navita Gupta  Satish T. Pote  Gyan C. Mishra
Affiliation:a National Center for Cell Science, University of Pune Campus, Pune 411 007, India
b Department of Periodontics and Oral Implantology, Dr. D.Y. Patil Dental College and Hospital, Pune, India
Abstract:Mesenchymal stem cells (MSCs) are capable of self-renewal and differentiation into multiple cell lineages. Presently, bone marrow is considered as a prime source of MSCs; however, there are some drawbacks and limitations in use of these MSCs for cell therapy. In this study, we demonstrate that human gingival tissue-derived MSCs have several advantages over bone marrow-derived MSCs. Gingival MSCs are easy to isolate, homogenous and proliferate faster than bone marrow MSCs without any growth factor. Importantly, gingival MSCs display stable morphology and do not loose MSC characteristic at higher passages. In addition, gingival MSCs maintain normal karyotype and telomerase activity in long-term cultures, and are not tumorigenic. Thus, we reveal that human gingiva is a better source of MSCs than bone marrow, and large number of functionally competent clinical grade MSCs can be generated in short duration for cell therapy in regenerative medicine and tissue engineering.
Keywords:BM, bone marrow   CFU-F, colony-forming unit-fibroblast   GT, gingival tissue   IBMX, isobutyl methyl xanthine   MSCs, mesenchymal stem cells   PD, population doubling   PPARγ2, peroxisome proliferator-activated receptor γ2   TPVG, trypsin phosphate versene glucose
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号